Ann: Estia Health Announces CEO and COO Succession, page-4

Mixed results. The revenue and EBITDA growth seems to be slowing down. However the amount of debt relative to EBITDA is significantly improved. The issue is the change to funding from the government surrounding these homes. However my initial reason for buying this stock was to gain exposure to the ageing Australian population. And as you can see in the image below that's only going to benefit EHE. But short term there may be some growing pains. But DYOR.